Zobrazeno 1 - 10
of 42
pro vyhledávání: '"L Gutierrez-Sainz"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Villamayor, L Gutierrez-Sainz, J A Garcia-Cuesta, D. Martinez-Perez, Ismael Ghanem, A. Custodio, J. Feliu, D. Viñal
Publikováno v:
Clinical and Translational Oncology. 23:1838-1846
Second-line (2L) treatments for advanced pancreatic ductal adenocarcinoma (PDAC) achieve a modest benefit at the expense of potential toxicity. In the absence of predictive factors of response, the identification of prognostic factors could help in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e87891d06523c814ec0333668f3ce337
https://doi.org/10.1007/s12094-021-02589-7
https://doi.org/10.1007/s12094-021-02589-7
Autor:
F Arias-Lotto, Patricia Cruz, S Martinez-Recio, L Gutierrez-Sainz, M I Esteban-Rodriguez, R A Gonzalez, Oliver Higuera, J De Castro-Carpeño
Publikováno v:
Clinical and Translational Oncology. 23:2030-2035
Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor, with a poor prognosis. MPM needs to find prognostic factors of survival. We provided the management of patients with MPM and sought to determine whether pre-treatment levels of deri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54a086529b47bd033d27193ccea1c19e
https://doi.org/10.1007/s12094-021-02605-w
https://doi.org/10.1007/s12094-021-02605-w
Autor:
J. Villamayor, Eugenia Espinosa, J Pedregosa, Ana Custodio, Darío Sanchez-Cabrero, D. Viñal, Beatriz Castelo, L Gutierrez-Sainz, Virginia Martínez-Marín, P. Zamora, J A Garcia-Cuesta, Andrés Redondo, J de Castro-Carpeño, Alvaro Pinto, Oliver Higuera, J. Feliu, Patricia Cruz, A Gallego, D. Martinez-Perez
Publikováno v:
Clinical and Translational Oncology. 23:1245-1252
Cancer and cancer therapies have been associated with an increased incidence of venous thromboembolic events (VTE). However, the incidence of VTE in patients on immunotherapy has not been well characterized. The aim of this study was to assess the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8a5edc3b58909f7ce7d4ab571f72dc0
https://doi.org/10.1007/s12094-020-02515-3
https://doi.org/10.1007/s12094-020-02515-3
Autor:
J. de Castro, J A Garcia-Cuesta, J. Feliu, L Gutierrez-Sainz, Nuria Rodríguez-Salas, Eugenia Espinosa, Daniel Tirapu Martínez, L. Ostios, Alvaro Pinto, Oliver Higuera, J Pedregosa, J. Villamayor, D. Viñal, Darío Sanchez-Cabrero
Publikováno v:
Clinical and Translational Oncology. 23:1185-1192
The prognostic value of neutrophil-to-lymphocyte ratio (NLR) has been extensively studied in cancer patients. However, the performance of NLR as an early marker of efficacy of immune checkpoint inhibitors (ICI) is still understudied. We studied the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cb5feb4a821a7b5b279d9ac3130ec82
https://doi.org/10.1007/s12094-020-02509-1
https://doi.org/10.1007/s12094-020-02509-1
Autor:
Daniel Tirapu Martínez, Virginia Martínez-Marín, J. Feliu, Andrés Redondo, S Martinez-Recio, Alberto Berjón, J A Garcia-Cuesta, Daniel Bernabeu, J.J. Pozo-Kreilinger, L Gutierrez-Sainz, A Gallego, Eugenia Espinosa, B. Belinchon, Marta Mendiola, Eduardo J. Ortiz-Cruz, D. Viñal, J. Villamayor
Publikováno v:
Clinical and Translational Oncology. 22:1849-1856
Soft tissue sarcomas (STS) have a high risk of relapse in spite of the use of (neo)adjuvant chemotherapy. In this context, looking for new prognostic biomarkers is an interesting field of research. Our aim is to analyze the prognostic impact of neutr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6f905124334534bdba408a9d70009c1
https://doi.org/10.1007/s12094-020-02324-8
https://doi.org/10.1007/s12094-020-02324-8
Autor:
L. Gutierrez-Sainz, S. López-Muñoz, P. Cruz-Castellanos, O. Higuera, M.I. Esteban-Rodríguez, I. Losantos-García, J. De Castro-Carpeño
Publikováno v:
ESMO Open. 7:100568
Tumor spread through air spaces (STAS) in lung adenocarcinoma is a novel mechanism of invasion. STAS has been proposed as an independent predictor of poor prognosis. The aim of this study was to evaluate the correlations between STAS status and other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d1cbaa7c2c29f236179668e9bb872e
https://doi.org/10.1016/j.esmoop.2022.100568
https://doi.org/10.1016/j.esmoop.2022.100568
Autor:
D. Viñal, S. Martinez-Recio, D. Martinez Perez, I. Ruiz, J. Peña, D. Jimenez-Bou, A. Rueda-Lara, G. Martin-Montalvo, M. Alameda, M. Palacios, A. Custodio, L. Gutierrez-Sainz, I. Ghanem, J. Feliu, N. Rodríguez-Salas
Publikováno v:
Annals of Oncology. 33:S261
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8066ca20e30fe7b142d5fc4c55405c4d
https://doi.org/10.1016/j.annonc.2022.04.132
https://doi.org/10.1016/j.annonc.2022.04.132
Publikováno v:
Current treatment options in oncologyReferences and Recommended ReadingPapers of particular interest, published recently, have been highlighted as: • Of importance. 22(10)
Worldwide, lung cancer is the most common cause of cancer morbidity and mortality. Despite a trend towards an escalating diagnosis of resectable non-small cell lung cancer (NSCLC), overall survival (OS) in patients with resectable NSCLC remains poor.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31f0b2a75f68b259e6584db1235cf5e3
https://pubmed.ncbi.nlm.nih.gov/34424417
https://pubmed.ncbi.nlm.nih.gov/34424417
Autor:
L, Gutierrez-Sainz, P, Cruz, S, Martinez-Recio, O, Higuera, M I, Esteban-Rodriguez, F, Arias-Lotto, R A, Gonzalez, J, De Castro-Carpeño
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 23(10)
Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor, with a poor prognosis. MPM needs to find prognostic factors of survival. We provided the management of patients with MPM and sought to determine whether pre-treatment levels of deri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::472c0dfa7acd331a709e1582d91f88f4
https://pubmed.ncbi.nlm.nih.gov/33837910
https://pubmed.ncbi.nlm.nih.gov/33837910